glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Osteogenic Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dedhar, S; Mitchell, MD; Pierschbacher, MD | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Osteogenic Sarcoma
Article | Year |
---|---|
The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties.
Topics: Alkaline Phosphatase; Cell Adhesion; Cell Differentiation; Cell Division; Cell Transformation, Neoplastic; Collagen; Fibronectins; Genetic Variation; Humans; Oligopeptides; Osteoblasts; Osteosarcoma; Phenotype; Prostaglandins; Receptors, Fibronectin; Receptors, Immunologic; Tumor Cells, Cultured | 1989 |